Dr. Eric Chenven
Urologist
1 Podcast on BackTable
Dr. Eric Chenven is the Chief of Urology at Broward Health Medical Center in Fort Lauderdale, Florida.
Learn from the experiences and expertise of Dr. Eric Chenven and other leading voices in your specialty on the BackTable app.
Episode # 191 • 01 Oct 2024
Optimizing Radiation Therapy: Role of Perirectal Spacers
What does recent research say about the role of perirectal spacers in prostate cancer treatment? In this episode of the BackTable Urology Podcast, host Dr. Jose Silva discusses the use of perirectal spacers for prostate radiotherapy with guests Dr. Eric Chenven, Chief of Urology at Broward Health Medical Center, and Dr. Nadim Nasr, a radiation oncologist at Arlington Radiation Oncology.
This podcast is supported by
More from Dr. Eric Chenven
About
Dr. Eric Chenven graduated cum laude with a bachelor's degree in biology from Brandeis University in Waltham, MA. He completed his medical degree at the Albert Einstein College of Medicine, and served his surgery and urology residencies at the Robert Wood Johnson Medical School in New Brunswick, NJ.
Dr. Chenven completed a fellowship in Endourology/Laparoscopy at the Thomas Jefferson University in Philadelphia, PA. He was awarded the Pfizer Scholar in Urology and the Gerald P. Murphy Scholar awards in his final year of residency. Recent research interests have included laparoscopic surgery, upper tract kidney tumors, PSA testing, kidney stones, and vasectomy.
He is certified by the American Board of Urology and is a member of the American Urological Association, American College of Surgeons, Endourology Society, and the American Medical Association. Dr. Chenven is currently the Chief of Urology at Broward Health Medical Center (BHMC). He sits on the Cancer Committee and the Surgical Quality Assurance Committee at BHMC, where he was formally also Medical Director for Laparoscopic and Minimally-Invasive Urologic Surgery. Dr. Chenven was selected as one of the Top Doctors in Broward and Palm Beach Counties by his fellow physicians and was listed for such in Gold Coast Magazine for 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, and 2023.
This BackTable podcast is sponsored by Boston Scientific’s Urology Division. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world; this includes solutions for Benign Prostatic Hyperplasia or BPH, one of the most prevalent urologic conditions facing men today. [1,2]
Boston Scientific’s RezūmTM Water Vapor Therapy is a minimally invasive BPH treatment that provides urologists with an efficient, durable solution that reduces prostate volume while preserving sexual function. [3,4] With proven efficacy, durability, and lower clinical progression rates than daily medications, AUA guidelines support a shared decision-making process for the consideration of RezūmTM as a first-line treatment and alternative to medications. [3,5,6] Additionally, if insufficiently treated, BPH can negatively
impact bladder function, making earlier intervention valuable for patients. [7] Give your patients an alternative to daily medications and long-lasting BPH relief with Rezum Therapy.
1. AUA Annual Census Report – 2021, https://www.auanet.org/research-and-data/aua-census
2. Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, Te AE, Kaplan SA. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016
May 5;2:16031. doi: 10.1038/nrdp.2016.31. PMID: 27147135
3. McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of Rezūm water
vapor thermal therapy for treatment of moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J
Urol. 2021 Sep;206(3):715-24.
4. Mynderse LA, Hanson D, Robb RA, et al. Rezūm System water vapor treatment for lower urinary tract symptoms/benign prostatic
hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional
renderings. Urology. 2015 Jul;86(1):122-7.
5. Gupta N, Rogers T, Holland B, et al. Three-year treatment outcomes of water vapor thermal therapy (Rezūm System) compared to
doxazosin, finasteride and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of
Prostatic Symptoms (MTOPS) Trial. J Urol. 2018 Aug;200(2):405-13.
6. Lerner LB, McVary, KT, Barry MJ et al: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA
Guideline. J Urol 2021; 206: 806.
7. Mirone V, Imbimbo C, Longo N, Fusco F. The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction. J Eur Uro. 2007, Vol 51
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All trademarks are the property of their respective owners.
©2023 Boston Scientific Corporation or its affiliates. All rights reserved. URO-1540313-AA MAR 2023
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.